ANDREW LOURENS: Open Payments
NPI 1568956456 · PONTE VEDRA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 39 payments from 24 companies in 2025. Trend: 2023 $604 · 2024 $1,047 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $100 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Becton, Dickinson and Company | 2 | $54 |
| Lilly USA, LLC | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Eisai Inc. | 1 | $32 |
Products named: Wegovy, Auvelity, MOUNJARO, ELIQUIS, SHINGRIX, GARDASIL 9, Ozempic, Leqembi.
Industry payments across FL — which companies pay providers there.
